ADRIENNE ACORD: Open Payments
NPI 1235817867 · RAVENSWOOD, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$508 in 22 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $440 · 2025 $508
Food & beverage: $409Education: $99
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 2 | $122 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $90 |
| Amgen Inc. | 3 | $57 |
| Lundbeck LLC | 3 | $54 |
| Otsuka America Pharmaceutical, Inc. | 3 | $53 |
| Novo Nordisk Inc | 3 | $45 |
| ABBVIE INC. | 1 | $21 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| Lilly USA, LLC | 1 | $18 |
| GlaxoSmithKline, LLC. | 1 | $15 |
Products named: REXULTI, CAPLYTA, OTEZLA, Ozempic, Veozah, UBRELVY, Auvelity, MOUNJARO.
Industry payments across WV — which companies pay providers there.
